| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/29/1992 | EP0468555A1 Pharmaceutical composition for rectal administration of active principles exhibiting a prevalently topical medication action at the colon level |
| 01/29/1992 | EP0468504A1 A novel antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 01/29/1992 | EP0468434A1 Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis |
| 01/29/1992 | EP0468257A1 Multimeric form of human rhinovirus receptor protein |
| 01/29/1992 | EP0468119A1 Novel carbocyclic analogs of certain nucleosides |
| 01/29/1992 | EP0467916A1 Aerosolized azole antifungals |
| 01/29/1992 | EP0126145B1 Tetracycline activity enhancement |
| 01/29/1992 | CN1058214A 1,3-oxathiolane nucleoside analogues |
| 01/29/1992 | CN1058208A Pharmaceutical compounds |
| 01/28/1992 | US5084461 Anticholesterol agents |
| 01/28/1992 | US5084449 Anti-bacterial compositions comprising a substituted bis-(4-aminophenyl)-sulfone and a dihydro-folic acid reductase |
| 01/28/1992 | US5084447 Antibiotics as bactericides |
| 01/28/1992 | US5084445 3'-azido-2',3'-dideoxy-5-methylcytidine |
| 01/28/1992 | CA2047509A1 Fungicides |
| 01/28/1992 | CA2046053A1 Antiviral antibiotic bu-4224v |
| 01/28/1992 | CA1294968C Quinoline carboxylic acid boric acid anhydrides and process for the preparation thereof |
| 01/28/1992 | CA1294960C 7-deazaguanines as immunomodulators |
| 01/27/1992 | WO1992001786A1 Portable ribozyme cassettes, dna sequences containing them, ribozymes encoded by these dna sequences, and compositions containing these ribozymes |
| 01/27/1992 | CA2088154A1 Portable ribozyme cassettes, dna sequences containing them, ribozyme encoded by these dna sequences, and compositions containing these ribozymes |
| 01/26/1992 | CA2047796A1 1-phenyl substituted-1h, 3h-thiazole [3,4-a] benimidazoles, process for their preparation and pharmaceutical compositions containing them |
| 01/25/1992 | CA2047390A1 Carbocyclic analogs of certain nucleosides |
| 01/24/1992 | WO1992001700A1 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides |
| 01/24/1992 | CA2047540A1 Continuous release pharmaceutical compositions |
| 01/23/1992 | WO1992001057A1 Ehv-4 glycoprotein vaccine |
| 01/23/1992 | WO1992001056A1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 01/23/1992 | WO1992001045A1 Equine herpesvirus-4 tk- vaccine |
| 01/23/1992 | WO1992000999A1 Fibroblast growth factor receptors |
| 01/23/1992 | WO1992000997A1 Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 01/23/1992 | WO1992000981A1 Novel 3-substituted cephem compounds and processes for preparation thereof |
| 01/23/1992 | WO1992000956A1 Inhibitors of aspartic proteases |
| 01/23/1992 | WO1992000954A1 Aspartic protease inhibitors |
| 01/23/1992 | WO1992000952A1 Hiv-inhibiting benzeneacetamide derivatives |
| 01/23/1992 | WO1992000948A1 Inhibitors of retroviral proteases |
| 01/23/1992 | WO1992000742A1 Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections |
| 01/23/1992 | CA2086740A1 Equine herpesvirus-4 tk-vaccine |
| 01/23/1992 | CA2086739A1 Ehv-4 glycoprotein vaccine |
| 01/23/1992 | CA2084508A1 Hiv-inhibiting benzeneacetamide derivatives |
| 01/22/1992 | EP0467869A1 Antiviral glove |
| 01/22/1992 | EP0467700A2 Coconjugate vaccines comprising immunogenic protein, HIV related peptides, and anionic moieties |
| 01/22/1992 | EP0467647A2 Thioalkylthio cephalosporin derivatives |
| 01/22/1992 | EP0467606A1 Rapamycin derivatives |
| 01/22/1992 | EP0467434A1 2-Biphenyl-carbapenem antibacterial agents |
| 01/22/1992 | EP0467331A1 O-methyl derivatives of azithromycin A, process and intermediates for their preparation, and use thereof in the preparation of pharmaceuticals |
| 01/22/1992 | EP0467185A2 Oligomers, their uses and formulations |
| 01/22/1992 | EP0466817A1 Recombinant trichosanthin and coding sequence |
| 01/22/1992 | CN1058021A 9-purinyl phosphonic acid derivatives |
| 01/21/1992 | US5082863 Bactericide, veterinary use |
| 01/21/1992 | US5082859 Derivatives of benzocycloalkenyldihydroxyalkanoic acids and medications containing them |
| 01/21/1992 | CA1294615C Semisynthetic erythromycin antibiotics |
| 01/20/1992 | WO1992001698A1 Antiviral phosphono-alken derivatives of purines |
| 01/20/1992 | WO1992001461A1 Asphodelus composition for increasing white blood cell count |
| 01/20/1992 | CA2359026A1 Intermediate compounds of thioalkylthio cephalosporin derivatives |
| 01/20/1992 | CA2087446A1 Antiviral phosphono-alken derivatives of purines |
| 01/20/1992 | CA2086933A1 Asphodelus composition for increasing white blood cell count |
| 01/20/1992 | CA2050635A1 Class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties, and vaccines containing same |
| 01/20/1992 | CA2047317A1 Amphiphilic peptide compositions and analogues thereof |
| 01/20/1992 | CA2047073A1 Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
| 01/20/1992 | CA2047031A1 Peptide-polysaccharide-protein conjugate vaccines |
| 01/19/1992 | WO1992001475A1 Compositions based on active principles of hydrophobic medicaments solubilizable in an aqueous solvent |
| 01/19/1992 | WO1992001467A1 Method for treating viral infections using oxidized lipoproteins |
| 01/19/1992 | CA2087536A1 Compositions based on active ingredients of hydrophobic drugs that can be sulubilized in an aqueous solvent |
| 01/19/1992 | CA2086921A1 Method for treating viral infections using oxidized lipoproteins |
| 01/19/1992 | CA2047041A1 Process for purification of hepatitis-a virus capsids |
| 01/17/1992 | CA2045842A1 Dna capable of site-specific integration into mycobacteria |
| 01/15/1992 | EP0466509A1 Heterocyclic derivatives |
| 01/15/1992 | EP0466498A1 Physiologically active peptides having immunoregulatory activities |
| 01/15/1992 | EP0466365A2 Novel immunosuppressant fermentation products of a microorganism |
| 01/15/1992 | EP0466254A1 2-naphthyl-carbapenems |
| 01/15/1992 | EP0466253A1 2-naphthyl-carbapenems |
| 01/15/1992 | EP0466037A2 Process for enhancing the resistance of aquatic animals to disease |
| 01/15/1992 | EP0465633A1 C4 binding protein fusion proteins |
| 01/15/1992 | EP0465561A1 Avirulent microbes and uses therefor |
| 01/15/1992 | EP0465529A1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 01/15/1992 | EP0465495A1 Ribozome inactivating proteins and derivatives thereof |
| 01/15/1992 | EP0462205A4 Leukocyte adhesion receptors |
| 01/15/1992 | EP0232405B1 Soluble phosphorylated glucan |
| 01/15/1992 | EP0230456B1 The protection of equines against streptococcus equi |
| 01/15/1992 | CN1057844A Process for preparation of pyrimidine nucleosides |
| 01/15/1992 | CN1057840A Antiviral tetrahydroimioazo (1,4) benzodiazepin-2-(thi) ones |
| 01/14/1992 | WO1992000988A1 Targeted drug delivery via phosphonate derivatives |
| 01/14/1992 | US5081271 Novel benzoic acid derivatives and process for preparing the same |
| 01/14/1992 | US5081237 3-alkenyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds |
| 01/14/1992 | US5081225 Gram-positive and gram-negative antibacterial compounds from the microorganism, janthinobacterium lividum |
| 01/14/1992 | US5081135 Bactericides |
| 01/14/1992 | US5081116 Cephalosporin derivatives |
| 01/14/1992 | US5081034 Genetic engineering |
| 01/14/1992 | US5081023 Antibiotic l53-18a and process for preparation thereof |
| 01/14/1992 | CA2087194A1 Targeted drug delivery via phosphonate derivatives |
| 01/14/1992 | CA1294282C 2-phenylpyrano¬2,3-b|pyridine compounds and process for their preparation |
| 01/14/1992 | CA1294280C 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof, processes for the preparation thereof, agents containing same, and the use thereof |
| 01/14/1992 | CA1294217C Pharmaceutical formulation for the treatment of bacterial infections |
| 01/13/1992 | WO1992001051A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/13/1992 | CA2087005A1 Immunogenic peptide sequence from echinococcus granulosus, dna sequence coding for said peptide sequence, and diagnostic and therapeutic uses thereof |
| 01/12/1992 | CA2046543A1 Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 01/12/1992 | CA2046524A1 2-naphthyl-carbapenem antibacterial agents |
| 01/12/1992 | CA2046505A1 2-naphthyl-carbapenem antibacterial agents |
| 01/11/1992 | WO1992001055A1 O-glycosylated ifn-alpha |
| 01/11/1992 | CA2084514A1 O-glycosylated ifn-alpha |
| 01/10/1992 | CA2046491A1 Oligomers, their uses and formulations |
| 01/09/1992 | WO1992000330A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |